Isotechnika Reports Final Results of the PROMISE Trial

27.05.2008 13:40:05
Isotechnika Inc.: Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. (TSX:ISA) today announced positive results from the Phase 2b PROMISE trial which evaluated the Company's lead drug, voclosporin , in de novo kidney transplant patients. This trial was designed to determine the most appropriate dosing strategy for the Phase 3 program in kidney transplantation."PROMISE has shown that the efficacy of voclosporin is statistically non-inferior when ...

Lesen Sie hier weiter... |  Drucken |  PDF

Ähnliche Artikel




politikportal.at: das APA-OTS-Portal für multimediale Presse ...

politikportal.at: das APA OTS-Portal für multimediale Presseaussendungen. Isotechnika Reports Final Results of the PROMISE Trial = 27.05.2008 / 13:07


Bankkaufmann - News

Auf dieser Seite finden Sie Neuigkeiten zum Thema: Aktuelle Wirtschaftsnews, Monat: 05 Isotechnika Reports Final Results of the PROMISE Trial.27.05.2008


Presseportal: Branchenansicht - Chemie

Die Datenbank für Pressematerial in Text, Bild und Ton von mehr als 15.000 Pressestellen aus Wirtschaft, Isotechnika Reports Final Results of the PROMISE


ots.at: das APA-OTS-Portal für multimediale Presseaussendungen

Isotechnika Presents Positive Data From the Promise Trial of Voclosporin at the Isotechnika Reports Final Results of the PROMISE Trial = 27.05.2008 / 13:07


Isotechnika Inc. Aktien | 934786 | CA4649041015 | IKA

Isotechnika to hold conference call to discuss positive PROMISE trial.CNX Marketlink Isotechnika selected for oral presentation at the American Transpla